Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Human Gene Therapy Methods|July 25, 2013
Rapid generation of stable cell lines expressing high levels of erythropoietin, factor VIII, and an antihuman CD20 antibody using lentiviral vectorsLajos Baranyi, Christopher B Doering, Gabriella Denning, et al.
Blood|May 21, 2021
Nonhuman glycans can regulate anti-factor VIII antibody formation in miceConnie M Arthur, Patricia E Zerra, Sooncheon Shin, et al.
Molecular Therapy Oncolytics|June 30, 2023
Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagersScott A Becker, Brian G Petrich, Bing Yu, et al.
Blood|January 11, 2011
Factor VIII A3 domain substitution N1922S results in hemophilia A due to domain-specific misfolding and hyposecretion of functional proteinRyan J Summers, Shannon L Meeks, John F Healey, et al.
Blood|August 11, 2005
High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitorsChristina Hausl, Rafi U Ahmad, Maria Sasgary, et al.
Journal of Thrombosis and Haemostasis : JTH|June 7, 2024
Structural basis for inhibition of coagulation factor VIII reveals a shared antigenic hotspot on the C1 domainKenneth C Childers, Ben Cowper, Jordan D Vaughan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2010
Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIIIH Trent Spencer, Gabriela Denning, Richard E Gautney, et al.
Frontiers in Immunology|June 28, 2021
Structure of Blood Coagulation Factor VIII in Complex With an Anti-C2 Domain Non-Classical, Pathogenic Antibody InhibitorEstelle K Ronayne, Shaun C Peters, Joseph S Gish, et al.
Blood|May 16, 2023
Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitorKenneth C Childers, Nathan G Avery, Kevin A Estrada Alamo, et al.
Frontiers in Cell and Developmental Biology|August 27, 2021
Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia AChristopher Stem, Christopher Rodman, Ritu M Ramamurthy, et al.
Pageof 8